Blood eosinophils and chronic obstructive pulmonary disease: a global initiative for chronic obstructive lung disease science committee 2022 review
D Singh, A Agusti, FJ Martinez, A Papi… - American journal of …, 2022 - atsjournals.org
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) published its first report
for the diagnosis and management of chronic obstructive pulmonary disease (COPD) in …
for the diagnosis and management of chronic obstructive pulmonary disease (COPD) in …
[HTML][HTML] Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.
A Corlateanu, Y Mendez, Y Wang, RJA Garnica… - Pulmonology, 2020 - Elsevier
Abstract Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous and
multisystemic disease with progressive increasing morbidity and mortality. COPD is now …
multisystemic disease with progressive increasing morbidity and mortality. COPD is now …
Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study
Background The concept that small conducting airways less than 2 mm in diameter become
the major site of airflow obstruction in chronic obstructive pulmonary disease (COPD) is well …
the major site of airflow obstruction in chronic obstructive pulmonary disease (COPD) is well …
Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD
M Miravitlles, JJ Soler-Cataluña, M Calle… - Archivos de …, 2012 - Elsevier
Recognizing the clinical heterogeneity of COPD suggests a specific therapeutic approach
directed by the so-called clinical phenotypes of the disease. The Spanish COPD Guidelines …
directed by the so-called clinical phenotypes of the disease. The Spanish COPD Guidelines …
Spanish guideline for COPD (gesEPOC). Update 2014
M Miravitlles, JJ Soler-Cataluña, M Calle… - Archivos de …, 2014 - Elsevier
The publication of the Spanish guideline for chronic obstructive pulmonary disease–COPD–
(GesEPOC) has brought about a change in the approach to the treatment of this disease …
(GesEPOC) has brought about a change in the approach to the treatment of this disease …
The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study
HO Coxson, A Dirksen, LD Edwards… - The lancet Respiratory …, 2013 - thelancet.com
Background Emphysema is a key contributor to airflow limitation in chronic obstructive
pulmonary disease (COPD) and can be quantified using CT scanning. We investigated the …
pulmonary disease (COPD) and can be quantified using CT scanning. We investigated the …
Diagnosis, assessment, and phenotyping of COPD: beyond FEV1
P Lange, DM Halpin, DE O'Donnell… - International journal of …, 2016 - Taylor & Francis
COPD is now widely recognized as a complex heterogeneous syndrome, having both
pulmonary and extrapulmonary features. In clinical practice, the diagnosis of COPD is based …
pulmonary and extrapulmonary features. In clinical practice, the diagnosis of COPD is based …
Pulmonary function testing in COPD: looking beyond the curtain of FEV1
Chronic obstructive pulmonary disease (COPD) management remains challenging due to
the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the …
the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the …
Contribution of adaptive immunity to human COPD and experimental models of emphysema
F Kheradmand, Y Zhang, DB Corry - Physiological Reviews, 2023 - journals.physiology.org
The pathophysiology of chronic obstructive pulmonary disease (COPD) and the undisputed
role of innate immune cells in this condition have dominated the field in the basic research …
role of innate immune cells in this condition have dominated the field in the basic research …
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
The 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) classifies patients
with chronic obstructive pulmonary disease (COPD) into four groups (A to D). We explored …
with chronic obstructive pulmonary disease (COPD) into four groups (A to D). We explored …